Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine dose and infusion-rate effects on cardiac function in elderly surgical patients
ChiCTR2000040989Phase 4Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dexmedetomidine (5 arms), sponsored by Jiangsu Provincial People's Hospital. Primary endpoints: Ejection fraction, Stroke volume and 6 more. Started May 2020; status: recruiting.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on ChiCTR2000040989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040989.